Treatment of spondyloarthropathies with antibodies against tumour necrosis factor alpha: first clinical and laboratory experiences.
Braun
J
J
Department of Medicine, Rheumatology, Benjamin Franklin Hospital, Free University Berlin, and German Rheumatology Research Centre, Berlin, Germany. jbraun@zedat.fu-berlin.de
Xiang
J
J
Brandt
J
J
Maetzel
H
H
Haibel
H
H
Wu
P
P
Kohler
S
S
Rudwaleit
M
M
Siegert
S
S
Radbruch
A
A
Thiel
A
A
Sieper
J
J
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D006801:Humans; D013166:Spondylitis / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000276:immunology*
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha